Clin2
NCT06609369Possibly a fitRecruiting

Sleep and smoking relapse study

Tobacco UseTobacco CessationInsomnia

Treatments studied

Part of Brain & nervous system, Mental health clinical trials.

This study tests whether improving sleep can help people quit smoking and avoid relapse. It uses brain scans, a quitting medication, and counseling.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
114 people
Ages
18 years to 65 years
Study type
Interventional

Who can take part

  • You can read and understand English
  • You have smoked cigarettes or used nicotine e-cigarettes heavily for more than 6 months
  • Your recent smoking or vaping will be confirmed by a test
  • You have a healthy body weight
  • You are not currently in a different smoking treatment program
  • You do not have a neurological or psychiatric condition that affects sleep or MRI safety

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07328594Not yet recruiting· Phase 4
Sleep medication to help smokers quit or cut back

This study tests whether a new sleep medication, daridorexant, can help smokers sleep better and feel more alert during the day, while also supporting their efforts to quit or reduce smoking. You will monitor your sleep at home, keep a diary, and take short mobile tests for 3 weeks.

Portland, Oregon
NCT07145866Recruiting· Phase 4
Varenicline and TMS for quitting nicotine use

This study tests whether combining the medication varenicline (Chantix) with a special brain stimulation treatment (TMS) can help people quit vaping or smoking nicotine. If you're motivated to quit and use nicotine daily, you may be able to join.

Boston, Massachusetts
NCT04725617Recruiting
Smoking-quit program for people with HIV and sleep issues

This study tests a wellness-based smoking-cessation program (including the stop-smoking medicine varenicline) for people living with HIV who want to quit. It aims to help you reduce or stop smoking while monitoring safety, sleep, and mental health during the program.

Phoenix, Arizona
NCT05726045Recruiting
Sleep-based brain training to help you quit smoking

This study tests a way to improve smoking cessation using special sleep-based brain stimulation and memory support. If it works, it may help you stay committed to quitting by strengthening helpful brain learning during sleep.

Mannheim, Baden-Wurttemberg
NCT07202351Recruiting
Sleep support for quitting smoking or cannabis

This trial tests whether adding sleep-focused help to standard quit-smoking or quit-cannabis therapy improves your chances of success. It is for people who are not already being treated for sleep problems.

Paris, Île-de-France Region
NCT06883162Recruiting· Phase 3
A study to help people stop smoking tobacco and reduce cannabis use

This study tests whether a medication called varenicline (or a placebo) can help people who use both tobacco and cannabis to quit or cut back. It takes place in South Carolina and lasts 12 weeks.

Charleston, South Carolina

Hear when a new Tobacco Use trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.